Reversing hair loss is notoriously difficult, but a new study may bring scientists one step closer to solving the hair loss puzzle. Share on Pinterest Approximately 88 million men and women experience some degree of hair loss during their lives. Those eager to reverse a receding hairline can choose from a few solutions. Hair transplants are a costly but permanent option. Topical solutions that promote hair growth, but at inconsistent rates, are another option. To date, scientists haven’t developed a surefire method to stop hair loss, scientifically known as androgenetic alopecia. That term alone provides clues to its illusive cure. Hair loss is the result of both hormonal and hereditary factors. The truth is, hair loss is still a bit of a mystery, said Dr. Edidiong Kaminska. She practices dermatology in Chicago and is a spokesperson for the American Academy of Dermatology. “There are so many molecular pathways — it’s multifactorial, it’s hereditary. There are a host of factors,” she told Healthline. “That’s why treating hair loss has been complicated and challenging.”

Uncovering a new possible treatment for hair loss A study released in May 2018 may bring scientists one step closer to solving the hair loss puzzle. It involves a drug that’s currently used to treat osteoporosis. One of the side effects of the drug is that it reduces the activity of a protein called SFRP1. This is key because that protein also stops follicles from growing hair. The researchers from the University of Manchester’s Centre for Dermatology Research uncovered this finding through lab tests. They used samples containing scalp hair follicles from more than 40 male hair-transplant patients. The hair follicles were placed in a medium and treated with the drug. Researchers said that those hair follicles were able to grow again because it suppressed the actions of SFRP1. The researchers published their findings in the journal PLOS Biology. Kaminska said it’s exciting to see that the researchers were able to zero in on the protein that stops hair from growing at the follicle. “This is novel because it blocked that protein, SFRP,” she said. “It’s amazing that they were able to find the specific protein.” But Kaminska stopped short of calling the findings a cure for baldness. For starters, she said it’s just the first study. Further, it was only conducted in the lab — not on people. There simply isn’t enough thorough research to draw serious conclusions yet about its long-term implications for hair loss. “I can’t say it’s the magic bullet, but it’s exciting,” she said.

From treating osteoporosis to fighting hair loss At first the researchers conducted studies using cyclosporine A, an immunosuppressant. One of its side effects is hair growth. That set of testing led them to the SFRP1 protein and the discovery that the protein blocks hair growth. But cyclosporine A has too many side effects to pursue further testing, which is why they set their sights on the osteoporosis drug. It has few side effects. It should be noted that the scientists didn’t provide the name of the drug in their study. Study author Nathan Hawkshaw, PhD, told the BBC that the treatment could make a real difference to people who have hair loss. “The fact that this new agent, which had never even been considered in a hair loss context, promotes human hair growth is exciting because of its translational potential,” he said in his statement.